Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy.
Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-years old woman with anaplastic thyroid cancer.
FASSINA, AMBROGIO;MARIONI, GINO;CONTE, PIERFRANCO
2015
Abstract
Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2015 Complete response to weekly carboplatin–docetaxel chemotherapy in a 91year old woman.pdf
Accesso riservato
Descrizione: Complete response to weekly carboplatin-docetaxel chemotherapy in a 91years old woman with anaplastic thyroid cancer
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
